Biochemical tests are laboratory analyses of body fluids, most often blood or urine, that measure the concentration of specific chemicals to help diagnose disease, monitor organ function, and guide treatment decisions. They range from a simple blood glucose check to complex panels that assess liver enzymes, kidney waste products, lipid levels, hormones, and proteins associated with heart damage or cancer. Clinical biochemistry, sometimes called chemical pathology, underpins much of modern medicine: the results on a standard lab report reflect dozens of these measurements, each one a window into how a particular organ or metabolic process is performing.
What a Basic Metabolic Panel Actually Tells You
When a doctor orders “blood work,” the core of it is usually a metabolic panel. This groups together measurements that, taken as a set, reveal how well your kidneys filter waste, how your body handles sugar, and whether your electrolytes are in balance. Glucose is the most familiar item: a fasting blood glucose above the normal range signals possible diabetes or pre-diabetes. Electrolytes like sodium, potassium, chloride, and bicarbonate reflect hydration, nerve function, and acid-base balance. Creatinine and blood urea nitrogen (BUN) track kidney performance, because these are waste products your kidneys are supposed to clear. When they accumulate, something is going wrong with filtration.
The kidney-specific markers deserve a closer look because they are among the most commonly misunderstood results. Creatinine by itself is a rough gauge, since your muscle mass, age, and sex all influence how much creatinine your body produces. For that reason, labs typically convert a raw creatinine value into an estimated glomerular filtration rate (eGFR) using formulas that account for age, sex, ethnicity, and sometimes weight. That converted number gives a much more practical picture of how well the kidneys are actually filtering blood.1PubMed Central. Estimated Glomerular Filtration Rate (eGFR): A Serum Creatinine-Based Test for the Detection of Chronic Kidney Disease and its Impact on Clinical Practice If you have ever wondered why your creatinine looked “fine” but your doctor still flagged the eGFR, that is why: the formula catches declining kidney function earlier than the raw number does.
Liver Function Tests
A liver panel typically includes enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT), along with bilirubin and albumin. These tests do not directly measure how “healthy” the liver is in some global sense. Instead, they reflect different types of damage or dysfunction. ALT and AST leak out of liver cells when those cells are injured, so elevated levels suggest hepatocellular damage from causes like viral hepatitis, fatty liver disease, or medication toxicity. Alkaline phosphatase and GGT tend to rise when bile flow is obstructed, pointing toward what clinicians call a cholestatic pattern.
Interpreting abnormal liver results starts with ruling out non-liver causes, since some of these enzymes are found in other tissues too. AST, for example, also comes from muscle and heart cells. Once non-hepatic causes are excluded, abnormal patterns are typically classified into cholestatic, hepatocellular, immunologic, or infiltrative disease categories, each pointing the clinician toward a different set of possible diagnoses.2Medical Clinics of North America. EVALUATION OF ABNORMAL LIVER FUNCTION TESTS Albumin and bilirubin, meanwhile, tell you about the liver’s synthetic and processing ability. Low albumin suggests the liver is not making enough protein; high bilirubin means it is struggling to process the breakdown products of old red blood cells.
Lipid Panels and Cardiovascular Risk
A standard lipid panel reports total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Most clinical guidelines focus on LDL as the primary treatment target, and for good reason: lowering LDL reduces heart attacks and strokes. But the picture is more nuanced than a single LDL number. Accumulating evidence shows that people who achieve low LDL levels but still have high non-HDL cholesterol or high apolipoprotein B remain at increased cardiovascular risk.3Nature Reviews Cardiology. Lipid parameters for measuring risk of cardiovascular disease Similarly, individuals with low HDL cholesterol are more likely to experience cardiovascular events even when their LDL looks acceptable.
Triglycerides add another layer. Large observational studies show that elevated triglycerides and reduced HDL cholesterol are both associated with increased cardiovascular risk.4European Heart Journal. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management However, the relationship between triglycerides and heart disease appears to be driven less by the triglyceride molecules themselves and more by the particles that carry them: triglyceride-rich lipoproteins and their remnants. In practical terms, if your LDL is under control but your triglycerides are elevated or your HDL is low, you still carry meaningful extra risk. One study of apparently healthy men and women found that among people with low LDL, those with elevated triglycerides had roughly 60% higher risk of coronary heart disease, and those with a high total-cholesterol-to-HDL ratio had about double the risk, compared to people with better numbers on those secondary markers.5PubMed. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women
Cardiac Troponin and Heart Attack Diagnosis
When someone arrives at an emergency department with chest pain, one of the first biochemical tests ordered is cardiac troponin. Troponins are proteins found inside heart muscle cells, and they spill into the bloodstream when those cells are damaged. A rise in troponin is the biochemical cornerstone of diagnosing a heart attack. Modern high-sensitivity troponin assays have made this detection faster and more reliable. In a landmark study, high-sensitivity cardiac troponin assays measured at the time a patient first presented to the emergency room had diagnostic accuracy around 0.95 to 0.96, compared with about 0.90 for the older standard assay.6PubMed. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays That improvement matters most in the early hours, when older tests could miss a heart attack still in progress.
Point-of-care troponin devices, small enough to sit beside the bed rather than in a central laboratory, are now approaching similar accuracy. A study of over 1,200 patients found that a point-of-care high-sensitivity troponin I test had an area under the curve of 0.95, at least comparable to the lab-based reference assays.7PubMed. Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I Researchers are even working on paper-based troponin sensors designed to be rapid, cheap, and usable outside hospital settings, with detection limits as low as 0.05 ng/mL and response times around one minute.8PubMed. Paper based point of care immunosensor for the impedimetric detection of cardiac troponin I biomarker A troponin result is not always a heart attack, though. Troponin can rise from heart failure, pulmonary embolism, myocarditis, sepsis, or even extreme endurance exercise. The test tells you that heart muscle has been stressed; the clinical context tells you why.
Blood Sugar and HbA1c
A single fasting glucose reading is a snapshot of right now. HbA1c (glycated hemoglobin) provides something more useful for managing diabetes: a measure of average blood sugar control over the preceding two to three months. It works because glucose sticks to hemoglobin in red blood cells, and since those cells live for about three months, the percentage of hemoglobin that has been “glycated” serves as a running average.9PubMed Central. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients An HbA1c below about 5.7% is considered normal; 5.7% to 6.4% signals pre-diabetes; and 6.5% or above is the diagnostic threshold for diabetes. Because it reflects long-term control, HbA1c is also used to adjust medications: a patient whose HbA1c drifts upward over several readings clearly needs a treatment change, even if their fasting glucose on any given morning looks passable.
Thyroid function tests occupy similar hormonal territory. The standard first-line test is thyroid stimulating hormone (TSH), sometimes followed by free T4 (thyroxine) and free T3 (triiodothyronine). TSH is released by the pituitary gland and tells the thyroid how much hormone to produce. If the thyroid is underperforming, TSH rises as the pituitary tries harder to stimulate it; if the thyroid is overactive, TSH drops because the pituitary backs off.10PubMed Central. Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status This inverse relationship makes TSH a sensitive early detector of thyroid trouble, often flagging a problem before T4 or T3 levels have clearly shifted.
Inflammation Markers
C-reactive protein (CRP) is one of the most commonly ordered biochemical markers for inflammation. It is an acute-phase protein produced by the liver in response to signals from the immune system, and it rises within four to six hours of an inflammatory trigger, peaking at roughly 36 to 50 hours before falling rapidly once the inflammation resolves.11PubMed. How to use: C-reactive protein Markedly elevated CRP usually points to infection, often bacterial.12PubMed Central. C-Reactive Protein: Clinical Relevance and Interpretation But CRP is not specific to infection alone. Levels can climb with obesity, periodontal disease, autoimmune conditions, and kidney dysfunction.13PubMed Central. C-Reactive Protein (CRP) and its Association with Periodontal Disease: A Brief Review Conversely, CRP may stay deceptively low in people with liver failure (because the liver makes it) or during flares of certain autoimmune diseases like lupus.
CRP outperforms the erythrocyte sedimentation rate (ESR), another common inflammation marker, in both responsiveness and specificity. ESR rises and falls slowly and is influenced by factors like anemia and age, making it a blunter tool. A newer variant called high-sensitivity CRP (hs-CRP) measures the same protein at lower concentrations and is used mainly for cardiovascular risk assessment, where chronic low-grade inflammation plays a role in plaque buildup. In that context, hs-CRP is not diagnosing an infection but flagging a smoldering vascular process.
Tumor Markers
Biochemical tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. Common examples include PSA (prostate-specific antigen), CA-125 (associated with ovarian cancer), CEA (carcinoembryonic antigen, linked to colorectal and other cancers), and AFP (alpha-fetoprotein, used in liver cancer and certain germ cell tumors). These markers are measured with blood tests and are widely used in clinical oncology. However, they carry an important caveat: non-cancerous conditions can also cause tumor markers to rise above normal levels, and not every cancer patient has an elevated marker.14PubMed Central. Tumor markers: A diagnostic tool
Because of this imperfect sensitivity and specificity, tumor markers are generally more useful for monitoring treatment response and detecting recurrence than for screening otherwise healthy people. If a patient with colon cancer has a high CEA level before surgery and it drops afterward, a later rise strongly suggests the cancer has come back. Using that same CEA test to screen the general population, though, would generate a flood of false alarms from benign conditions like smoking and inflammatory bowel disease. The clinical value of tumor markers lies in how they are used, not just in what they measure.
Urinalysis and Non-Blood Tests
Not all biochemical tests require a blood draw. Urinalysis is one of the oldest and most accessible: a simple dipstick test can screen for glucose, ketones, protein, blood, bilirubin, and several other substances. Finding glucose in urine, for instance, suggests blood glucose has exceeded the kidney’s ability to reabsorb it, a hallmark of uncontrolled diabetes. One audit found that dipstick testing for elevated glucose had a sensitivity of 83% and a specificity of 93% when compared against a reference standard.15Pathology. How sensitive and specific is urinalysis ‘dipstick’ testing for detection of hyperglycaemia and ketosis? An audit of findings from coronial autopsies Ketone testing on the same dipstick is highly sensitive but far less specific, meaning it catches true positives well but also flags many negatives incorrectly. Other body fluids, including cerebrospinal fluid, pleural fluid, and saliva, can also undergo biochemical analysis depending on the clinical question.
Why the Sample Type Matters
A detail that rarely makes it onto the patient’s radar but deeply affects results is whether the lab uses serum or plasma, and which collection tube the blood goes into. Serum is the liquid left after blood clots and the clot is removed. Plasma is the liquid portion when clotting is prevented by an anticoagulant in the tube. For many tests the two are interchangeable, but for others the difference matters. Several metabolites show statistically significant alterations between serum and different plasma types, and even lipoproteins are affected by the choice of blood collection tube.16PubMed Central. Serum or Plasma (and Which Plasma), That Is the Question In practice, labs often have standard tube types for each test, but the choice is not trivial. Matrix-related effects can limit the ability to consolidate all analyses onto a single tube, and these differences are sometimes underestimated in clinical practice.17PubMed. Sample management for clinical biochemistry assays: Are serum and plasma interchangeable specimens? If you have ever noticed that a repeat test came back slightly different from the first, the tube type might be part of the story.
What “Normal” Really Means on a Lab Report
Every result on a lab report comes with a reference range, and most people assume that falling inside it means healthy while falling outside means trouble. The reality is more subtle. Reference ranges are typically derived from a population of apparently healthy people and represent the central 95% of values in that group. By definition, 5% of perfectly healthy individuals will fall outside the “normal” range on any given test. Your own personal normal may sit consistently at the high end or low end of that population range without signifying disease.
This individual variation is what scientists call biological variation. Each person has a biological set point around which a given biomarker naturally fluctuates because of genetics, diet, age, and physical activity.18British Journal of Biomedical Science. The Role and Limitations of the Reference Interval Within Clinical Chemistry and Its Reliability for Disease Detection The variation within one person over time tends to be much smaller than the variation across the whole population. A creatinine that is normal for the population but represents a sharp rise from your personal baseline may be clinically significant, even though it does not breach the reference range. This is why trends over serial measurements often reveal more than any single number, and why some experts advocate for individualized reference intervals based on a patient’s own historical data.
Point-of-Care Testing and Its Trade-Offs
Traditional biochemical tests require sending a sample to a central laboratory, where large automated analyzers process hundreds or thousands of specimens per day.19PubMed Central. Clinical Chemistry Laboratory Automation in the 21st Century – Amat Victoria curam (Victory loves careful preparation) Point-of-care (POC) testing puts a smaller version of that analytical power right in the clinic, pharmacy, or even the patient’s home. Glucose meters are the most familiar example, but POC devices now cover HbA1c, lipids, troponin, hemoglobin, and more.
Accuracy has improved considerably. A newer POC HbA1c device showed results that were highly correlated with reference laboratory methods, with very small average biases from fingerstick and venous samples alike.20PubMed Central. Accuracy and Precision of a Point-of-Care HbA1c Test That said, not all POC devices perform equally well across the entire measurement range. An earlier comparison of a different POC HbA1c monitor found good overall correlation with lab results but noted that the most accurate readings fell within a particular mid-range window, and one patient’s value would have led to a different clinical decision if the clinician had relied on the POC number alone.21PubMed. Comparison of point-of-care HbA1c test versus standardized laboratory testing For hemoglobin measurement, a comparison of noninvasive and invasive POC devices against a laboratory analyzer found average biases of about -0.1 g/dL for both, but with enough variability around that average to warrant caution in critical decisions.22PubMed Central. Accuracy of noninvasive hemoglobin and invasive point-of-care hemoglobin testing compared with a laboratory analyzer POC testing is excellent for speed and convenience, but for high-stakes decisions, lab confirmation usually follows.
Therapeutic Drug Monitoring
Some biochemical tests are not about diagnosing disease but about making sure a medication is doing its job without causing harm. Therapeutic drug monitoring (TDM) measures the concentration of specific drugs in a patient’s blood at timed intervals to keep the dose in a sweet spot: high enough to be effective, low enough to avoid toxicity. This is not necessary for most medications, only for drugs with a narrow window between the dose that helps and the dose that harms, drugs whose absorption and metabolism vary widely from person to person, and drugs whose effects are hard to gauge clinically without a blood level.23PubMed Central. Overview of therapeutic drug monitoring Classic examples include certain anti-seizure drugs, the immunosuppressants used after organ transplants, lithium for bipolar disorder, and some antibiotics like vancomycin and aminoglycosides. For these drugs, routine blood levels are a standard part of care, not an optional add-on.
Newborn Screening
One of the most consequential applications of biochemical testing happens within the first couple of days of life. Newborn screening programs use a few drops of blood from a baby’s heel to test for dozens of inherited metabolic disorders. The technology that made this possible at scale is tandem mass spectrometry, which can identify more than 30 metabolic conditions from a single dried blood spot in about two to three minutes.24PubMed Central. Newborn Screening for inherited metabolic disorders; news and views These conditions are individually rare but collectively not uncommon, and many cause irreversible damage if missed.
When tandem mass spectrometry was introduced to newborn screening, the detection rate for inborn errors of metabolism increased substantially. In one large cohort study, the prevalence of detected inborn errors (excluding phenylketonuria, which was already screened for) roughly doubled compared with historical rates, jumping to about 15.7 per 100,000 births. Detection rates increased specifically for medium-chain acyl-CoA dehydrogenase deficiency, a disorder of fat metabolism that can cause sudden death in infants, and for other fatty-acid oxidation disorders.25PubMed. Screening newborns for inborn errors of metabolism by tandem mass spectrometry Finding these conditions early, before symptoms appear, allows treatment such as dietary modification or enzyme replacement to begin immediately, often preventing intellectual disability, organ damage, or death.
How the Tests Work Behind the Scenes
You do not need to know the inner workings of laboratory instruments to understand your results, but two widely used methods are worth a brief mention because they show up in nearly every lab. Spectrophotometry measures how much light a sample absorbs at a particular wavelength. If a chemical reaction produces a colored product and the intensity of that color is proportional to the concentration of the substance being measured, the spectrophotometer quantifies it. This principle underlies a huge number of routine clinical chemistry tests.26PubMed Central. The Role of Spectrophotometric Standards in the Clinical Chemistry Laboratory
The enzyme-linked immunosorbent assay, or ELISA, works differently. It uses antibodies that bind specifically to a target molecule, combined with an enzyme label that produces a color change when the target is present. This antigen-antibody approach makes ELISA highly specific and is the workhorse for detecting hormones, infectious agents, drug levels, and proteins at very low concentrations.27PubMed Central. An overview of ELISA: a review and update on best laboratory practices for quantifying peptides and proteins in biological fluids Between spectrophotometry for routine chemistry and immunoassays for targeted detection, the vast majority of biochemical tests you will encounter in a standard lab report are covered.